β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceBalance Sheet
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Cash And Cash Equivalents | Short Term Investments | Cash And Short Term Investments | Net Receivables | Inventory | Other Current Assets | Total Current Assets | Property Plant Equipment Net | Goodwill | Intangible Assets | Goodwill And Intangible Assets | Long Term Investments | Tax Assets | Other Non Current Assets | Total Non Current Assets | Other Assets | Total Assets | Account Payables | Short Term Debt | Tax Payables | Deferred Revenue | Other Current Liabilities | Total Current Liabilities | Long Term Debt | Deferred Revenue Non Current | Deferred Tax Liabilities Non Current | Other Non Current Liabilities | Total Non Current Liabilities | Other Liabilities | Capital Lease Obligations | Total Liabilities | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Income Loss | Other Total Stockholders Equity | Total Stockholders Equity | Total Equity | Total Liabilities And Stockholders Equity | Minority Interest | Total Liabilities And Total Equity | Total Investments | Total Debt | Net Debt |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03 | 94582.0 | 379.0 | 94961.0 | 90539.0 | 43185.0 | 7454.0 | 236139.0 | 71576.0 | 8303.0 | 75516.0 | 83819.0 | 33400.0 | 0.0 | 10765.0 | 199560.0 | 0.0 | 435699.0 | 43531.0 | 0.0 | 5127.0 | 0.0 | 44138.0 | 92796.0 | 0.0 | 0.0 | 0.0 | 37534.0 | 37534.0 | 0.0 | 0.0 | 130330.0 | 0.0 | 8777.0 | 240029.0 | 0.0 | 57249.0 | 306055.0 | 305370.0 | 435699.0 | -685.0 | 435699.0 | 24406.0 | 35158.0 | -94582.0 |
2023-03 | 57903.0 | 774.0 | 58677.0 | 107165.0 | 39352.0 | 8906.0 | 213326.0 | 66173.0 | 7385.0 | 96309.0 | 96309.0 | 42560.0 | 2810.0 | 1.0 | 207853.0 | 0.0 | 421179.0 | 44945.0 | 0.0 | 6745.0 | -3056.0 | 37814.0 | 89504.0 | 0.0 | 7277.0 | 1592.0 | 29509.0 | 38378.0 | 0.0 | 0.0 | 127882.0 | 256198.0 | 8702.0 | 238071.0 | 37781.0 | 9425.0 | 293979.0 | 293296.0 | 421861.0 | -683.0 | 421861.0 | 37359.0 | 36207.0 | -21696.0 |
2022-03 | 83014.0 | 1293.0 | 84307.0 | 99591.0 | 37141.0 | 9680.0 | 229426.0 | 56287.0 | 13715.0 | 130217.0 | 130217.0 | 40944.0 | 3103.0 | 0.0 | 230551.0 | -1.0 | 459976.0 | 41185.0 | 0.0 | 4198.0 | -13965.0 | 50438.0 | 95821.0 | 0.0 | 11161.0 | 2526.0 | 13624.0 | 27311.0 | 0.0 | 0.0 | 123132.0 | 307802.0 | 8672.0 | 290477.0 | 29686.0 | 8652.0 | 337488.0 | 336843.0 | 460620.0 | -645.0 | 460620.0 | 36238.0 | 32932.0 | -50082.0 |
2021-03 | 62888.0 | 527.0 | 63415.0 | 95992.0 | 41575.0 | 5776.0 | 206231.0 | 39489.0 | 26858.0 | 112876.0 | 112876.0 | 40933.0 | 2824.0 | 0.0 | 196122.0 | 0.0 | 402353.0 | 38106.0 | 2912.0 | 5458.0 | -2912.0 | 32073.0 | 78549.0 | 0.0 | 9551.0 | 3290.0 | 7203.0 | 16754.0 | 0.0 | 2912.0 | 95303.0 | 287150.0 | 8525.0 | 270757.0 | 20435.0 | 8020.0 | 307585.0 | 307050.0 | 402353.0 | -535.0 | 402353.0 | 37065.0 | 10146.0 | -52742.0 |
2020-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more balance sheet data for Santen Pharmaceutical!
Sign up for free or log inπ Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting